NEUROCYSTICERCOSIS

NEUROCYSTICERCOSIS was reported 45 times

NEUROCYSTICERCOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 7 0.0024
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
3 Lipid-based Polyene Antifungal [EPC] 1 0.0001
4 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
5 Antimetabolite Immunosuppressant [EPC] 1 0.0000
6 Antimycobacterial [EPC] 1 0.0000
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
8 Microtubule Inhibitor [EPC] 5 0.0000
9 Polyene Antifungal [EPC] 1 0.0000
10 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
11 Platinum-based Drug [EPC] 5 0.0000
12 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
13 Aromatase Inhibitor [EPC] 2 0.0000
14 Mood Stabilizer [EPC] 3 0.0000
15 Purine Antimetabolite [EPC] 1 0.0000
16 Acetylcholine Release Inhibitor [EPC] 1 0.0000
17 Antirheumatic Agent [EPC] 1 0.0000
18 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
19 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
20 Corticosteroid [EPC] 10 0.0000
21 Fluoroquinolone Antibacterial [EPC] 1 0.0000
22 Azole Antifungal [EPC] 1 0.0000
23 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
24 Interferon beta [EPC] 1 0.0000
25 Anti-epileptic Agent [EPC] 1 0.0000
26 Insulin Analog [EPC] 2 0.0000
27 Alkylating Drug [EPC] 1 0.0000
28 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
29 Kinase Inhibitor [EPC] 2 0.0000
30 Platelet Aggregation Inhibitor [EPC] 2 0.0000
31 Osmotic Laxative [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
34 Benzodiazepine [EPC] 1 0.0000